{
    "clinical_study": {
        "@rank": "156620", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Evaluate the effect of bromocriptine on luteinizing hormone (LH) secretion\n      by suppression of prolactin and stimulation of dopaminergic receptors in early pubertal boys\n      and girls.\n\n      II.  Evaluate the effect of baclofen on LH secretion by stimulation of gamma-aminobutyric\n      acid receptors in early pubertal boys and girls."
        }, 
        "brief_title": "Pilot Study of the Effect of Baclofen and Bromocriptine on Luteinizing Hormone Secretion in Pubertal Children", 
        "condition": "Growth Disorders", 
        "condition_browse": {
            "mesh_term": "Growth Disorders"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Participants receive bromocriptine or baclofen followed by nocturnal measurements of\n      luteinizing hormone, growth hormone, and sex steroids. Pituitary reserve is evaluated with\n      the administration of gonadotropin-releasing hormone, and in children undergoing assessment\n      of short stature, standard provocative stimuli."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Short stature and/or constitutional growth delay\n\n          -  No epilepsy or risk of epilepsy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "4", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004793", 
            "org_study_id": "199/11923", 
            "secondary_id": "UMMC-1354"
        }, 
        "keyword": [
            "constitutional growth delay", 
            "endocrine disorders", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of Michigan", 
            "last_name": "Carol M. Foster", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004793"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Michigan", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1995", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}